BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20393019)

  • 1. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
    Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH
    Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence.
    O'Rourke N; Macbeth F
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):347-55. PubMed ID: 20427167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Langer CJ
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):108-16. PubMed ID: 10210549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer.
    Wendland MM; Sause WT
    Semin Surg Oncol; 2003; 21(2):111-21. PubMed ID: 14508861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.
    Belani CP; Aisner J
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):79-90. PubMed ID: 8052878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation.
    Penland SK; Socinski MA
    Semin Radiat Oncol; 2004 Oct; 14(4):326-34. PubMed ID: 15558508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
    Hennequin C; Girard N; Mornex F
    Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant chemoradiation in non-small cell lung cancer].
    Milleron B; Girard N; Gounant V; Mornex F
    Cancer Radiother; 2007; 11(1-2):36-40. PubMed ID: 17055314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concurrent chemoradiation in lung cancer].
    Girard N; Mornex F
    Bull Cancer; 2005 Dec; 92(12):1048-64. PubMed ID: 16396751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
    Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Akerley W; DeVore RF
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):36-43. PubMed ID: 10190782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer].
    Fournel P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S94-100. PubMed ID: 18235400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemoradiation for locally advanced non-small cell lung cancer].
    Girard N; Mornex F
    Cancer Radiother; 2007; 11(1-2):67-76. PubMed ID: 17208031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies.
    Williams TM; Maier A
    Cancer J; 2013; 19(3):272-81. PubMed ID: 23708074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy before surgery for non-small cell lung cancer.
    Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
    Rays; 2004; 29(4):445-52. PubMed ID: 15852734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.